Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
CNS Pharmaceuticals, Inc. (CNSP) had Operating Cash Flow per Share of $-537.81 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-14.86M |
|
-- |
|
-- |
|
$14.90M |
|
$-14.90M |
|
$0.04M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.86M |
|
$-14.90M |
|
$-14.90M |
|
0.03M |
|
0.03M |
|
$-466.63 |
|
$-466.63 |
|
| Balance Sheet Financials | |
$8.66M |
|
$0.01M |
|
$0.04M |
|
$8.70M |
|
$2.52M |
|
-- |
|
-- |
|
$2.52M |
|
$6.18M |
|
$6.18M |
|
$6.18M |
|
0.12M |
|
| Cash Flow Statement Financials | |
$-17.11M |
|
$-0.00M |
|
$23.03M |
|
$0.55M |
|
$6.46M |
|
$5.91M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.43 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-240.55% |
|
-240.55% |
|
-170.76% |
|
-240.55% |
|
$52.44 |
|
$-537.94 |
|
|
Operating Cash Flow per Share |
$-537.81 |